Is Synergy Pharmaceuticals going out of business?
Synergy Pharmaceuticals (NASDAQ:SGYP) has filed for Chapter 11 bankruptcy in a voluntary petition with another pharmaceutical company absorbing most of the company's assets once the move goes through.
Why did Synergy Pharmaceuticals Close?
Synergy filed for bankruptcy after failing to amend the liquidity and revenue covenants of its loan facility with private lender CRG. Bausch Health has offered $200 million for its assets; other bids may be forthcoming, but shareholders will almost certainly be wiped out.
What is Sgyp?
(SGYP) Company Bio. Synergy Pharmaceuticals is a biopharmaceutical company focused on the development of novel therapies for the treatment of gastrointestinal (GI) diseases and disorders. The company was founded in 2005 and is based in New York, New York.
Who bought Synergy Pharmaceuticals?
Bausch Health Companies Inc.LAVAL, Quebec , Feb. 26, 2019 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") announced today that the Company was selected as the successful bidder to acquire certain assets of Synergy Pharmaceuticals Inc.
Is Synergy Pharmaceuticals a real company?
Synergy Pharmaceuticals, LLC operates as a biopharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases.
How were Synergy Pharmaceuticals' earnings last quarter?
Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) released its quarterly earnings data on Thursday, November, 8th. The biopharmaceutical company reported...
Who are Synergy Pharmaceuticals' key executives?
Synergy Pharmaceuticals' management team includes the following people: Mr. Troy Hamilton Pharm.D. , CEO & Director (Age 47) Mr. Gary G. Gemigna...
Who are some of Synergy Pharmaceuticals' key competitors?
Some companies that are related to Synergy Pharmaceuticals include Amgen (AMGN) , Gilead Sciences (GILD) , Vertex Pharmaceuticals (VRTX) , Rege...
What other stocks do shareholders of Synergy Pharmaceuticals own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Synergy Pharmaceuticals investors own include Novavax (NVA...
What is Synergy Pharmaceuticals' stock symbol?
Synergy Pharmaceuticals trades on the NASDAQ under the ticker symbol "SGYP."
How much money does Synergy Pharmaceuticals make?
Synergy Pharmaceuticals (NASDAQ:SGYP) has a market capitalization of $0.00 and generates $16.82 million in revenue each year. The biopharmaceutical...
What is Synergy Pharmaceuticals' official website?
The official website for Synergy Pharmaceuticals is www.synergypharma.com .
How can I contact Synergy Pharmaceuticals?
Synergy Pharmaceuticals' mailing address is 420 LEXINGTON AVENUE SUITE 2012, NEW YORK NY, 10170 . The biopharmaceutical company can be reached via...
What other stocks do shareholders of Synergy Pharmaceuticals own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Synergy Pharmaceuticals investors own include Novavax (NVAX), Immunomedics (IMMU), Progenics Pharmaceuticals (PGNX), Inovio Pharmaceuticals (INO), ACADIA Pharmaceuticals (A CAD), Cara Therapeutics (CARA), OPKO Health (OPK), Gilead Sciences (GILD), Exelixis (EXEL) and (SLS).
What is Synergy Pharmaceuticals' official website?
The official website for Synergy Pharmaceuticals is www.synergypharma.com.
How can I contact Synergy Pharmaceuticals?
The biopharmaceutical company can be reached via phone at 212-297-0020 or via email at [email protected].
Does Synergy Pharmaceuticals pay dividends?
Synergy Pharmaceuticals does not currently pay a dividend.
SGYP Target Price
SGYP price target in 14 days: 0.0435 USD* upside and 0.000001 USD* downside. (Highest and lowest possible predicted price in a 14 day period)
Synergy Pharmaceuticals, Inc. ( SGYP ) Stock Market info
Recommendations: Buy or sell Synergy Pharmaceuticals stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Synergy Pharmaceuticals share forecasts, stock quote and buy / sell signals below.
Also on walletinvestor.com
asaptowing2727_1296 — whats going on with hcmc .i am waiting sine 2019 ,plz let me know my friends should i wait and how long???
SPDR S&P 500 ETF Trust (NYSEARCA:SPY) Price Target and Consensus Rating
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy).
Analyst Price Target Consensus
Sign-up to receive the latest news and ratings for SPY and its competitors with MarketBeat's FREE daily newsletter.
Analyst Ratings By Month
The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Average Share Price and Price Target by Month
The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target.
SPDR S&P 500 ETF Trust (NYSEARCA:SPY) Analyst Ratings Frequently Asked Questions
According to the issued ratings of 1 analysts in the last year, the consensus rating for SPDR S&P 500 ETF Trust stock is Hold based on the current 1 hold rating for SPYthe . Learn more on SPY's analyst rating history
